Potential Impact of Omega 6/3 Ratio and CD68+ Macrophage Infiltration on Survival in NSCLC Patients Undergoing Pulmonary Resection
Authors:
- Carlos DénizCDCarlos Déniz
- Camilo MorenoCamilo Moreno
- Iván MacíaIMIván Macía
- Francisco RivasFRFrancisco Rivas
- Anna UreñaAUAnna Ureña
- Anna MuñozAMAnna Muñoz
- Ines SerratosaISInes Serratosa
- Samantha AsoSASamantha Aso
- Marta GarcíaMGMarta García
- Cristina Masuet-AumatellCMCristina Masuet-Aumatell
- Ignacio EscobarIEIgnacio Escobar
- Ricard RamosRRRicard Ramos
Open Access
- 30 August 2024
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 31 (9) , 5098-5106
Abstract
Background: Lung cancer remains the leading cause of cancer-related mortality worldwide with non-small cell lung cancer (NSCLC) accounting for the majority of cases. The stage of detection significantly influences survival rates with early-stage diagnosis offering the best prognosis. This study investigates the prognostic impact of the omega-6/omega-3 ratio and tumor infiltration by CD8+ lymphocytes and CD68+ macrophages on overall survival (OS) and disease-free survival (DFS) in NSCLC patients undergoing pulmonary resection. Methods: We conducted a retrospective analysis of 53 patients with early-stage NSCLC who underwent pulmonary resection between September 2017 and January 2020. The omega-6/omega-3 ratio was quantified using gas chromatography and spectrometry. Tumor infiltration by CD8 and CD68 was assessed through immunohistochemistry. Survival outcomes were evaluated using Kaplan-Meier and Cox regression analyses. Results: An increased omega-6/omega-3 ratio and higher CD68+ macrophage infiltration were associated with a trend towards worse OS and DFS in NSCLC patients, though these results did not reach statistical significance. CD8+ T-cell infiltration was associated with improved survival outcomes, confirming its role as a favorable prognostic marker. Comparative analysis with existing datasets revealed similar demographic and clinical characteristics, reinforcing the generalizability of our findings. Conclusions: The omega-6/omega-3 ratio and CD68+ macrophage infiltration serve as important factors potentially influencing prognosis in NSCLC patients undergoing pulmonary resection. These findings highlight the need for further research to refine the prognostic utility of these biomarkers and to explore therapeutic strategies targeting inflammation and immune cell infiltration.Keywords
This publication has 23 references indexed in Scilit:
- Lung cancer screeningThe Lancet, 2022
- Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated InflammationImmunity, 2019
- Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancerEuropean Journal of Surgical Oncology, 2018
- Cancer survival in adult patients in Spain. Results from nine population-based cancer registriesClinical and Translational Oncology, 2017
- Innate and adaptive immune cells in the tumor microenvironmentNature Immunology, 2013
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012European Journal of Cancer, 2013
- Marine polyunsaturated fatty acids and cancer therapyBritish Journal of Cancer, 2013
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- The changing epidemiology of lung cancer in EuropeLung Cancer, 2003
- The importance of the ratio of omega-6/omega-3 essential fatty acidsBiomedicine & Pharmacotherapy, 2002